Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) EPS (Basic) (2019 - 2025)

Korro Bio's EPS (Basic) history spans 7 years, with the latest figure at -$5.32 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 135.4% year-over-year to -$5.32, compared with a TTM value of -$12.47 through Dec 2025, down 32.8%, and an annual FY2025 reading of -$12.48, down 33.19% over the prior year.
  • EPS (Basic) for Q4 2025 was -$5.32 at Korro Bio, down from -$1.92 in the prior quarter.
  • The five-year high for EPS (Basic) was $147.86 in Q4 2023, with the low at -$225.59 in Q4 2022.
  • Average EPS (Basic) over 5 years is -$15.25, with a median of -$2.26 recorded in 2024.
  • Year-over-year, EPS (Basic) tumbled 35707.94% in 2022 and then skyrocketed 165.54% in 2023.
  • Tracing KRRO's EPS (Basic) over 5 years: stood at -$0.63 in 2021, then tumbled by 35707.94% to -$225.59 in 2022, then soared by 165.54% to $147.86 in 2023, then plummeted by 101.53% to -$2.26 in 2024, then crashed by 135.4% to -$5.32 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's EPS (Basic) are -$5.32 (Q4 2025), -$1.92 (Q3 2025), and -$2.74 (Q2 2025).